THE EVALUATION OF IN-FLIGHT MEDICAL CARE ABOARD SELECTED U.S. AIR CARRIERS: 1996 TO 1997

Medical care in-flight and the Federal Aviation Administration (FAA)-mandated medical kit have been studied for many years. This study includes a detailed correlation between in-flight medical care, patient response in-flight, and post-flight follow-up, in an effort to evaluate in-flight medical care delivery on U.S. airlines and re-evaluate the FAA-mandated in-flight medical kit. A survey of five U.S. domestic air carriers from October 1, 1996 to September 30, 1997, showed 1,132 in-flight medical incidents. These airlines accounted for approximately 22% of scheduled US domestic enplanements during the period. There was good overall agreement between in-flight and post-flight diagnoses (70% of cases), and passenger condition improved in a majority of cases (60%), suggesting that in-flight diagnoses were generally accurate and treatment was appropriate. Results indicated that bronchodilator inhalers, oral antihistamines, and non-narcotic analgesics, all of which were obtained from other passengers, were used frequently enough to support a suggestion to include them in the medical kit.

Language

  • English

Media Info

  • Features: Appendices; References; Tables;
  • Pagination: 26 p.

Subject/Index Terms

Filing Info

  • Accession Number: 00929920
  • Record Type: Publication
  • Report/Paper Numbers: DOT/FAA/AM-00/13
  • Files: NTL, TRIS, USDOT
  • Created Date: Aug 11 2002 12:00AM